woman in white scrub suit holding gray laptop computer

Danae UroGeomics

Danae Urogenomics is a leading company in bladder cancer diagnostics. Our state-of-the-art diagnostic systems allow us to offer high-quality services for the detection and monitoring of this disease. We collaborate with scientific institutions and hospitals to continuously improve our diagnostic and prognostic methods. Our scientific partnerships and institutional collaborations ensure the accuracy and effectiveness of our diagnostics.

At Danae Urogenomics, we offer innovative and non-invasive urine-based diagnostic solutions for bladder cancer, enhancing diagnostic accuracy and supporting personalized therapeutic decisions. Our mission is to contribute to a more efficient, less invasive, and patient-centered medicine through the implementation of cutting-edge technology.

Mission

Vision

To become global leaders in the detection and management of bladder cancer, setting new standards in non-invasive diagnostics and personalized care. We aspire to transform the clinical approach to cancer worldwide through precision technology-based solutions that improve therapeutic outcomes and patients' quality of life.

Mission & Vision

BlaDimiR

BlaDimiR is an in vitro diagnostic system for detecting bladder cancer in urine by measuring specific microRNAs.
It uses quantitative PCR (qPCR) technology to provide a precise and non-invasive diagnosis, improving accuracy and reducing the need for invasive procedures such as cystoscopy.

BlaDimiRIO anticipates the effectiveness of combined BCG and anti-PD-L1 therapies through the joint analysis of a microRNA and cytokine signature in urine samples, allowing precise patient stratification in complex clinical contexts.

BlaDimiRplus

Products

BlaDimiRIO

BlaDimiRplus predicts the likelihood of response to BCG immunotherapy by detecting a specific microRNA signature in urine, enabling personalized therapeutic decisions from early stages.

Contact Us Now

Complete the form below to get in touch

Danae UroGeomics

Mission

Vision

Mission & Vision

BlaDimiR is an in vitro diagnostic system for detecting bladder cancer in urine by measuring specific microRNAs.
It uses quantitative PCR (qPCR) technology to provide a precise and non-invasive diagnosis, improving accuracy and reducing the need for invasive procedures such as cystoscopy.

BlaDimiRIO anticipates the effectiveness of combined BCG and anti-PD-L1 therapies through the joint analysis of a microRNA and cytokine signature in urine samples, allowing precise patient stratification in complex clinical contexts.

Products

BlaDimiRplus predicts the likelihood of response to BCG immunotherapy by detecting a specific microRNA signature in urine, enabling personalized therapeutic decisions from early stages.

Contact Us Now

Information

Social

Danae UroGeomics

Mission

Vision

Mission & Vision

BlaDimiR is an in vitro diagnostic system for detecting bladder cancer in urine by measuring specific microRNAs.It uses quantitative PCR (qPCR) technology to provide a precise and non-invasive diagnosis, improving accuracy and reducing the need for invasive procedures such as cystoscopy.

BlaDimiRIO anticipates the effectiveness of combined BCG and anti-PD-L1 therapies through the joint analysis of a microRNA and cytokine signature in urine samples, allowing precise patient stratification in complex clinical contexts.

Products

BlaDimiRplus predicts the likelihood of response to BCG immunotherapy by detecting a specific microRNA signature in urine, enabling personalized therapeutic decisions from early stages.

Contact Us Now

Information

Social

BlaDimiR is an in vitro diagnostic system for detecting bladder cancer in urine by measuring specific microRNAs.
It uses quantitative PCR (qPCR) technology to provide a precise and non-invasive diagnosis, improving accuracy and reducing the need for invasive procedures such as cystoscopy.